메뉴 건너뛰기




Volumn 10, Issue 6, 2008, Pages 496-504

Current management of hypertrophic cardiomyopathy

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ALDOSTERONE; AMIODARONE; ANGIOTENSIN; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIBIOTIC AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DISOPYRAMIDE; DIURETIC AGENT; LOSARTAN; METOPROLOL; PERHEXILINE; PRACTOLOL; PROPRANOLOL; RENIN; SARCOMERE PROTEIN; SPIRONOLACTONE; STRUCTURAL PROTEIN; UNCLASSIFIED DRUG; VERAPAMIL; WARFARIN;

EID: 58849115974     PISSN: 10928464     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11936-008-0042-9     Document Type: Review
Times cited : (10)

References (54)
  • 1
    • 2942530660 scopus 로고    scopus 로고
    • Hypertrophic cardiomyopathy
    • Elliott P, McKenna WJ: Hypertrophic cardiomyopathy. Lancet 2004, 363:1881-1891.
    • (2004) Lancet , vol.363 , pp. 1881-1891
    • Elliott, P.1    McKenna, W.J.2
  • 2
    • 0037070514 scopus 로고    scopus 로고
    • Hypertrophic cardiomyopathy: A systematic review
    • Maron BJ: Hypertrophic Aardiomyopathy: a systematic review. JAMA 2002, 287:1308-1320.
    • (2002) JAMA , vol.287 , pp. 1308-1320
    • Maron, B.J.1
  • 3
    • 0036796263 scopus 로고    scopus 로고
    • Phenotypic diversity in hypertrophic cardiomyopathy
    • Arad M, Seidman JG, Seidman CE: Phenotypic diversity in hypertrophic cardiomyopathy. Hum Mol Genet 2002, 11:2499-2506.
    • (2002) Hum Mol Genet , vol.11 , pp. 2499-2506
    • Arad, M.1    Seidman, J.G.2    Seidman, C.E.3
  • 4
    • 41949084114 scopus 로고    scopus 로고
    • Disease-modifying mutations in familial hypertrophic cardiomyopathy: Complexity from simplicity
    • Hilfiker-Kleiner D, Knoll R: Disease-modifying mutations in familial hypertrophic cardiomyopathy: Complexity from simplicity. Circulation 2008, 117:1775-1777.
    • (2008) Circulation , vol.117 , pp. 1775-1777
    • Hilfiker-Kleiner, D.1    Knoll, R.2
  • 5
    • 40649100317 scopus 로고    scopus 로고
    • Hypertrophic cardiomyopathy: The genetic determinants of clinical disease expression
    • Keren A, Syrris P, McKeTna WJ: Hypertrophic cardiomyopathy: the genetic determinants of clinical disease expression. Nat Clin Pract Cardiovasc Med 2008, 5:158-168.
    • (2008) Nat Clin Pract Cardiovasc Med , vol.5 , pp. 158-168
    • Keren, A.1    Syrris, P.2    McKenna, W.J.3
  • 6
    • 38349086961 scopus 로고    scopus 로고
    • Classification of the cardiomyopathies: A position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases
    • Elliott P, Andersson B, Arbustini E, et al.: Classification of the cardiomyopathies: A position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2008, 29:270-276.
    • (2008) Eur Heart J , vol.29 , pp. 270-276
    • Elliott, P.1    Andersson, B.2    Arbustini, E.3
  • 7
    • 33646693410 scopus 로고    scopus 로고
    • Contemporary definitions and classification of the cardiomyopathies: An American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention
    • Maron BJ, Towbin JA, Thiene G, et al.: Contemporary definitions and classification of the cardiomyopathies: An American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 2006, 113:1807-1816.
    • (2006) Circulation , vol.113 , pp. 1807-1816
    • Maron, B.J.1    Towbin, J.A.2    Thiene, G.3
  • 8
    • 0242522154 scopus 로고    scopus 로고
    • American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines
    • Maron BJ, McKenna WJ, Danielson GK, et al.: American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 2003, 42:1687-1713.
    • (2003) J Am Coll Cardiol , vol.42 , pp. 1687-1713
    • Maron, B.J.1    McKenna, W.J.2    Danielson, G.K.3
  • 9
    • 33751250500 scopus 로고    scopus 로고
    • Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction
    • Maron MS, Olivotto I, Zenovich AG, et al.: Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation 2006, 114:2232-2239.
    • (2006) Circulation , vol.114 , pp. 2232-2239
    • Maron, M.S.1    Olivotto, I.2    Zenovich, A.G.3
  • 10
    • 0037461605 scopus 로고    scopus 로고
    • Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy
    • Maron MS, Olivotto I, Betocchi S, et al.: Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med 2003, 348:295-303.
    • (2003) N Engl J Med , vol.348 , pp. 295-303
    • Maron, M.S.1    Olivotto, I.2    Betocchi, S.3
  • 11
    • 0031984468 scopus 로고    scopus 로고
    • Mechanism of benefit of negative inotropes in obstructive hypertrophic cardiomyopathy
    • Sherrid MV, Pearle G, Gunsburg DZ: Mechanism of benefit of negative inotropes in obstructive hypertrophic cardiomyopathy. Circulation 1998, 97:41-47.
    • (1998) Circulation , vol.97 , pp. 41-47
    • Sherrid, M.V.1    Pearle, G.2    Gunsburg, D.Z.3
  • 12
    • 0002560471 scopus 로고
    • Effects of beta adrenergic blockade on the circulation with particular reference to observations in patients with hypertrophic subaortic stenosis
    • Harrison DC, Braunwald E, Glick G, et al.: Effects of beta adrenergic blockade on the circulation with particular reference to observations in patients with hypertrophic subaortic stenosis. Circulation 1964, 29:84-98.
    • (1964) Circulation , vol.29 , pp. 84-98
    • Harrison, D.C.1    Braunwald, E.2    Glick, G.3
  • 13
    • 0015792616 scopus 로고
    • Double-blind trial of propranolol and practolol in hypertrophic cardiomyopathy
    • Hubner PJ, Ziady GM, Lane GK, et al.: Double-blind trial of propranolol and practolol in hypertrophic cardiomyopathy. Br Heart J 1973, 35:1116-1123.
    • (1973) Br Heart J , vol.35 , pp. 1116-1123
    • Hubner, P.J.1    Ziady, G.M.2    Lane, G.K.3
  • 14
    • 0033571197 scopus 로고    scopus 로고
    • A cohort study of childhood hypertrophic cardiomyopathy: Improved survival following high-dose beta-adrenoceptor antagonist treatment
    • Ostman-Smith I, Wettrell G, Riesenfeld T: A cohort study of childhood hypertrophic cardiomyopathy: Improved survival following high-dose beta-adrenoceptor antagonist treatment. J Am Coll Cardiol 1999, 34:1813-1822.
    • (1999) J Am Coll Cardiol , vol.34 , pp. 1813-1822
    • Ostman-Smith, I.1    Wettrell, G.2    Riesenfeld, T.3
  • 15
    • 0019452704 scopus 로고
    • Verapamil: Its potential for causing serious complications in patients with hypertrophic cardiomyopathy
    • EpsteIn SE, Rosing DR: Verapamil: its potential for causing serious complications in patients with hypertrophic cardiomyopathy. Circulation 1981, 64:437-441.
    • (1981) Circulation , vol.64 , pp. 437-441
    • Epstein, S.E.1    Rosing, D.R.2
  • 16
    • 0018721067 scopus 로고
    • Verapamil therapy: A new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. II. Effects on exercise capacity and symptomatic status
    • Rosing DR, KeAt KM, Maron BJ, Epstein SE: Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. II. Effects on exercise capacity and symptomatic status. Circulation 1979, 60:1208-1213.
    • (1979) Circulation , vol.60 , pp. 1208-1213
    • Rosing, D.R.1    Kent, K.M.2    Maron, B.J.3    Epstein, S.E.4
  • 17
    • 0023812613 scopus 로고
    • Disopyramide in hypertrophic cardiomyopathy. I. Hemodynamic assessment after intravenous administration
    • Pollick C, Kimball B, Henderson M, Wigle ED: Disopyramide in hypertrophic cardiomyopathy. I. Hemodynamic assessment after intravenous administration. Am J Cardiol 1988, 62:1248-1251.
    • (1988) Am J Cardiol , vol.62 , pp. 1248-1251
    • Pollick, C.1    Kimball, B.2    Henderson, M.3    Wigle, E.D.4
  • 18
    • 17144401887 scopus 로고    scopus 로고
    • Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy
    • Sherrid MV, Barac I, McKenna WJ, et al.: Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 2005, 45:1251-1258.
    • (2005) J Am Coll Cardiol , vol.45 , pp. 1251-1258
    • Sherrid, M.V.1    Barac, I.2    McKenna, W.J.3
  • 19
    • 0021811221 scopus 로고
    • Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia
    • McKenna WJ, Oakley CM, Krikler DM, Goodwin JF: Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia. Br Heart J 1985, 53:412-416.
    • (1985) Br Heart J , vol.53 , pp. 412-416
    • McKenna, W.J.1    Oakley, C.M.2    Krikler, D.M.3    Goodwin, J.F.4
  • 20
    • 0037116544 scopus 로고    scopus 로고
    • Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy
    • Maron BJ, Olivotto I, Bellone P, et al.: Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2002, 39:301-307.
    • (2002) J Am Coll Cardiol , vol.39 , pp. 301-307
    • Maron, B.J.1    Olivotto, I.2    Bellone, P.3
  • 21
    • 26844513376 scopus 로고    scopus 로고
    • Dilated-hypokinetic evolution of hypertrophic cardiomyopathy: Prevalence, incidence, risk factors, and prognostic implications in pediatric and adult patients
    • Biagini E, Coccolo F, Ferlito M, et al.: Dilated-hypokinetic evolution of hypertrophic cardiomyopathy: Prevalence, incidence, risk factors, and prognostic implications in pediatric and adult patients. J Am Coll Cardiol 2005, 46:1543-1550.
    • (2005) J Am Coll Cardiol , vol.46 , pp. 1543-1550
    • Biagini, E.1    Coccolo, F.2    Ferlito, M.3
  • 22
    • 12144288228 scopus 로고    scopus 로고
    • Aldosterone, through novel signaling proteins, is a fundamental molecular bridge between the genetic defect and the cardiac phenotype of hypertrophic cardiomyopathy
    • Tsybouleva N, Zhang L, Chen S, et al.: Aldosterone, through novel signaling proteins, is a fundamental molecular bridge between the genetic defect and the cardiac phenotype of hypertrophic cardiomyopathy. Circulation 2004, 109:1284-1291.
    • (2004) Circulation , vol.109 , pp. 1284-1291
    • Tsybouleva, N.1    Zhang, L.2    Chen, S.3
  • 23
    • 0035852766 scopus 로고    scopus 로고
    • Angiotensin II blockade reverses myocardial fibrosis in a transgenic mouse model of human hypertrophic cardiomyopathy
    • Lim DS, Lutucuta S, Bachireddy P, et al.: Angiotensin II blockade reverses myocardial fibrosis in a transgenic mouse model of human hypertrophic cardiomyopathy. Circulation 2001, 103:789-791.
    • (2001) Circulation , vol.103 , pp. 789-791
    • Lim, D.S.1    Lutucuta, S.2    Bachireddy, P.3
  • 24
    • 28044470767 scopus 로고    scopus 로고
    • Effect of Losartan on left ventricular diastolic function in patients with nonobstructive hypertrophic cardiomyopathy
    • Araujo AQ, Arteaga E, Ianni BM, et al.: Effect of Losartan on left ventricular diastolic function in patients with nonobstructive hypertrophic cardiomyopathy. Am J Cardiol 2005, 96:1563-1567.
    • (2005) Am J Cardiol , vol.96 , pp. 1563-1567
    • Araujo, A.Q.1    Arteaga, E.2    Ianni, B.M.3
  • 25
    • 0033608947 scopus 로고    scopus 로고
    • Infective endocarditis in hypertrophic cardiomyopathy: Prevalence, incidence, and indications for antibiotic prophylaxis
    • Spirito P, Rapezzi C, Bellone P, et al.: Infective endocarditis in hypertrophic cardiomyopathy: Prevalence, incidence, and indications for antibiotic prophylaxis. Circulation 1999, 99:2132-2137.
    • (1999) Circulation , vol.99 , pp. 2132-2137
    • Spirito, P.1    Rapezzi, C.2    Bellone, P.3
  • 26
    • 34250759244 scopus 로고    scopus 로고
    • Prevention of infective endocarditis: Guidelines from the American Heart Association: A guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young
    • Wilson W, Taubert KA, Gewitz M, et al.: Prevention of infective endocarditis: Guidelines from the AmericanAHeart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2007, 116:1736-1754.
    • (2007) Circulation , vol.116 , pp. 1736-1754
    • Wilson, W.1    Taubert, K.A.2    Gewitz, M.3
  • 28
    • 34547937694 scopus 로고    scopus 로고
    • Surgical myectomy versus alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Will there ever be a randomized trial?
    • Olivotto I, Ommen SR, Maron MS, et al.: Surgical myectomy versus alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Will there ever be a randomized trial? J Am Coll Cardiol 2007, 50:831-834.
    • (2007) J Am Coll Cardiol , vol.50 , pp. 831-834
    • Olivotto, I.1    Ommen, S.R.2    Maron, M.S.3
  • 29
    • 8344263111 scopus 로고    scopus 로고
    • Clinical and echocardiographic determinants of long-term survival after surgical myectomy in obstructive hypertrophic cardiomyopathy
    • Woo A, Williams WG, Choi R, et al.: Clinical and echocardiographic determinants of long-term survival after surgical myectomy in obstructive hypertrophic cardiomyopathy. Circulation 2005, 111:2033-2041.
    • (2005) Circulation , vol.111 , pp. 2033-2041
    • Woo, A.1    Williams, W.G.2    Choi, R.3
  • 30
    • 15944418799 scopus 로고    scopus 로고
    • Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy
    • Ommen SR, Maron BJ, Olivotto I, et al.: Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 2005, 46:470-476.
    • (2005) J Am Coll Cardiol , vol.46 , pp. 470-476
    • Ommen, S.R.1    Maron, B.J.2    Olivotto, I.3
  • 31
    • 36448992594 scopus 로고    scopus 로고
    • Long-term follow-up after percutaneous septal ablation in hypertrophic obstructive cardiomyopathy
    • Seggewiss H, Rigopoulos A, Welge D, et al.: Long-term follow-up after percutaneous septal ablation in hypertrophic obstructive cardiomyopathy. Clin Res Cardiol 2007, 96:856-863.
    • (2007) Clin Res Cardiol , vol.96 , pp. 856-863
    • Seggewiss, H.1    Rigopoulos, A.2    Welge, D.3
  • 32
    • 0033536029 scopus 로고    scopus 로고
    • Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. A randomized, double-blind, crossover study (M-PATHY)
    • Maron BJ, Nishimura RA, McKenna WJ, et al.: Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. A randomized, double-blind, crossover study (M-PATHY). Circulation 1999, 99:2927-2933.
    • (1999) Circulation , vol.99 , pp. 2927-2933
    • Maron, B.J.1    Nishimura, R.A.2    McKenna, W.J.3
  • 33
    • 8544240103 scopus 로고    scopus 로고
    • Pacing in hypertrophic obstructive cardiomyopathy. A randomized crossover study PIC
    • Study Group
    • Kappenberger L, Linde C, Daubert C, et al.: Pacing in hypertrophic obstructive cardiomyopathy. A randomized crossover study PIC. Study Group. Eur Heart J 1997, 18:1249-1256.
    • (1997) Eur Heart J , vol.18 , pp. 1249-1256
    • Kappenberger, L.1    Linde, C.2    Daubert, C.3
  • 34
    • 33144463910 scopus 로고    scopus 로고
    • Efficacy of catheter ablation of atrial fibrillation in patients with hypertrophic obstructive cardiomyopathy
    • Kilicaslan F, Verma A, Saad E, et al.: Efficacy of catheter ablation of atrial fibrillation in patients with hypertrophic obstructive cardiomyopathy. Heart Rhythm 2006, 3:275-280.
    • (2006) Heart Rhythm , vol.3 , pp. 275-280
    • Kilicaslan, F.1    Verma, A.2    Saad, E.3
  • 35
    • 34248670679 scopus 로고    scopus 로고
    • Usefulness and safety of transcatheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy
    • Gaita F, Di Donna P, Olivotto I, et al.: Usefulness and safety of transcatheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy. Am J Cardiol 2007, 99:1575-1581.
    • (2007) Am J Cardiol , vol.99 , pp. 1575-1581
    • Gaita, F.1    Di Donna, P.2    Olivotto, I.3
  • 36
    • 0031029791 scopus 로고    scopus 로고
    • Dual chamber pacing in hypertrophic obstructive cardiomyopathy: Beneficial effect of atrioventricular junction ablation for optimal left ventricular capture and filling
    • Jeanrenaud X, Schlapfer J, Fromer M, et al.: Dual chamber pacing in hypertrophic obstructive cardiomyopathy: Beneficial effect of atrioventricular junction ablation for optimal left ventricular capture and filling. Pacing Clin Electrophysiol 1997, 20:293-300.
    • (1997) Pacing Clin Electrophysiol , vol.20 , pp. 293-300
    • Jeanrenaud, X.1    Schlapfer, J.2    Fromer, M.3
  • 37
    • 33846504376 scopus 로고    scopus 로고
    • Regression of dilated-hypokinetic hypertrophic cardiomyopathy by biventricular cardiac pacing
    • Ashrafian H, Mason MJ, Mitchell AG: Regression of dilated-hypokinetic hypertrophic cardiomyopathy by biventricular cardiac pacing. Europace 2007, 9:50-54.
    • (2007) Europace , vol.9 , pp. 50-54
    • Ashrafian, H.1    Mason, M.J.2    Mitchell, A.G.3
  • 38
    • 42749088983 scopus 로고    scopus 로고
    • Effect of biventricular pacing on symptoms and cardiac remodelling in patients with end-stage hypertrophic cardiomyopathy
    • Rogers DP, Marazia S, Chow AW, et al.: Effect of biventricular pacing on symptoms and cardiac remodelling in patients with end-stage hypertrophic cardiomyopathy. Eur J Heart Fail 2008, 10:507-513.
    • (2008) Eur J Heart Fail , vol.10 , pp. 507-513
    • Rogers, D.P.1    Marazia, S.2    Chow, A.W.3
  • 39
    • 34247518789 scopus 로고    scopus 로고
    • Resynchronization or dyssynchronization-successful treatment with biventricular stimulation of a child with obstructive hypertrophic cardiomyopathy without dyssynchrony
    • Lenarczyk R, Kowalski O, Kukulski T, et al.: Resynchronization or dyssynchronization-successful treatment with biventricular stimulation of a child with obstructive hypertrophic cardiomyopathy without dyssynchrony. J Cardiovasc Electrophysiol 2007, 18:542-544.
    • (2007) J Cardiovasc Electrophysiol , vol.18 , pp. 542-544
    • Lenarczyk, R.1    Kowalski, O.2    Kukulski, T.3
  • 40
    • 38849201181 scopus 로고    scopus 로고
    • Heart transplantation in hypertrophic cardiomyopathy
    • Biagini E, Spirito P, Leone O, et al.: Heart transplantation in hypertrophic cardiomyopathy. Am J Cardiol 2008, 101:387-392.
    • (2008) Am J Cardiol , vol.101 , pp. 387-392
    • Biagini, E.1    Spirito, P.2    Leone, O.3
  • 41
    • 33744470092 scopus 로고    scopus 로고
    • Historical trends in reported survival rates in patients with hypertrophic cardiomyopathy
    • Elliott PM, Gimeno JR, Thaman R, et al.: Historical trends in reported survival rates in patients with hypertrophic cardiomyopathy. Heart 2006, 92:785-791.
    • (2006) Heart , vol.92 , pp. 785-791
    • Elliott, P.M.1    Gimeno, J.R.2    Thaman, R.3
  • 42
    • 0033667442 scopus 로고    scopus 로고
    • Sudden death in hypertrophic cardiomyopathy: Identification of high risk patients
    • Elliott PM, Poloniecki J, Dickie S, et al.: Sudden death in hypertrophic cardiomyopathy: Identification of high risk patients. J Am Coll Cardiol 2000, 36:2212-2218.
    • (2000) J Am Coll Cardiol , vol.36 , pp. 2212-2218
    • Elliott, P.M.1    Poloniecki, J.2    Dickie, S.3
  • 43
    • 33748863805 scopus 로고    scopus 로고
    • ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death-executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines
    • Zipes DP, Camm AJ, Borggrefe M, et al.: ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death-executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Eur Heart J 2006, 27:2099-2140.
    • (2006) Eur Heart J , vol.27 , pp. 2099-2140
    • Zipes, D.P.1    Camm, A.J.2    Borggrefe, M.3
  • 44
    • 0034628458 scopus 로고    scopus 로고
    • Sudden death in hypertrophic cardiomyopathy
    • Watkins H: Sudden death in hypertrophic cardiomyopathy. N Engl J Med 2000, 342:422-424.
    • (2000) N Engl J Med , vol.342 , pp. 422-424
    • Watkins, H.1
  • 45
    • 38849097178 scopus 로고    scopus 로고
    • Sudden cardiac arrest in hypertrophic cardiomyopathy in the absence of conventional criteria for high risk status
    • Maron BJ, Maron MS, Lesser JR, et al.: Sudden cardiac arrest in hypertrophic cardiomyopathy in the absence of conventional criteria for high risk status. Am J Cardiol 2008, 101:544-547.
    • (2008) Am J Cardiol , vol.101 , pp. 544-547
    • Maron, B.J.1    Maron, M.S.2    Lesser, J.R.3
  • 46
    • 0038076143 scopus 로고    scopus 로고
    • Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance
    • Moon JC, McKenna WJ, McCrohon JA, et al.: Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol 2003, 41:1561-1567.
    • (2003) J Am Coll Cardiol , vol.41 , pp. 1561-1567
    • Moon, J.C.1    McKenna, W.J.2    McCrohon, J.A.3
  • 47
    • 0032103098 scopus 로고    scopus 로고
    • Implications of left ventricular remodeling in hypertrophic cardiomyopathy
    • Maron BJ, Spirito P: Implications of left ventricular remodeling in hypertrophic cardiomyopathy. Am J Cardiol 1998, 81:1339-1344.
    • (1998) Am J Cardiol , vol.81 , pp. 1339-1344
    • Maron, B.J.1    Spirito, P.2
  • 48
    • 4344705206 scopus 로고    scopus 로고
    • Proposal for contemporary screening strategies in families with hypertrophic cardiomyopathy
    • Maron BJ, Seidman JG, Seidman CE: Proposal for contemporary screening strategies in families with hypertrophic cardiomyopathy. J Am Coll Cardiol 2004, 44:2125-2132.
    • (2004) J Am Coll Cardiol , vol.44 , pp. 2125-2132
    • Maron, B.J.1    Seidman, J.G.2    Seidman, C.E.3
  • 49
    • 0037145830 scopus 로고    scopus 로고
    • Risk associated with pregnancy in hypertrophic cardiomyopathy
    • Autore C, Conte MR, Piccininno M, et al.: Risk associated with pregnancy in hypertrophic cardiomyopathy. J Am Coll Cardiol 2002, 40:1864-1869.
    • (2002) J Am Coll Cardiol , vol.40 , pp. 1864-1869
    • Autore, C.1    Conte, M.R.2    Piccininno, M.3
  • 50
    • 0022395427 scopus 로고
    • Perioperative anesthetic risk of noncardiac surgery in hypertrophic obstructive cardiomyopathy
    • Thompson RC, Liberthson RR, Lowenstein E: Perioperative anesthetic risk of noncardiac surgery in hypertrophic obstructive cardiomyopathy. JAMA 1985, 254:2419-2421.
    • (1985) JAMA , vol.254 , pp. 2419-2421
    • Thompson, R.C.1    Liberthson, R.R.2    Lowenstein, E.3
  • 51
    • 24144462322 scopus 로고    scopus 로고
    • Recommendations for competitive sports participation in athletes with cardiovascular disease: A consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology
    • Pelliccia A, Fagard R, Bjornstad HH, et al.: Recommendations for competitive sports participation in athletes with cardiovascular disease: A consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J 2005, 26:1422-1445.
    • (2005) Eur Heart J , vol.26 , pp. 1422-1445
    • Pelliccia, A.1    Fagard, R.2    Bjornstad, H.H.3
  • 52
    • 2942624120 scopus 로고    scopus 로고
    • Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases
    • Maron BJ, Chaitman BR, Ackerman MJ, et al.: Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases. Circulation 2004, 109:2807-2816.
    • (2004) Circulation , vol.109 , pp. 2807-2816
    • Maron, B.J.1    Chaitman, B.R.2    Ackerman, M.J.3
  • 53
    • 0032491158 scopus 로고    scopus 로고
    • Impact of laboratory molecular diagnosis on contemporary diagnostic criteria for genetically transmitted cardiovascular diseases: Hypertrophic cardiomyopathy, long-QT syndrome, and Marfan syndrome. A statement for healthcare professionals from the Councils on Clinical Cardiology, Cardiovascular Disease in the Young, and Basic Science, American Heart Association
    • Maron BJ, Moller JH, Seidman CE, et al.: Impact of laboratory molecular diagnosis on contemporary diagnostic criteria for genetically transmitted cardiovascular diseases: Hypertrophic cardiomyopathy, long-QT syndrome, and Marfan syndrome. A statement for healthcare professionals from the Councils on Clinical Cardiology, Cardiovascular Disease in the Young, and Basic Science, American Heart Association. Circulation 1998, 98:1460-1471.
    • (1998) Circulation , vol.98 , pp. 1460-1471
    • Maron, B.J.1    Moller, J.H.2    Seidman, C.E.3
  • 54
    • 20044380514 scopus 로고    scopus 로고
    • Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: Proposal for a common European protocol
    • Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology
    • Corrado D, Pelliccia A, Bjornstad HH, et al.: Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: Proposal for a common European protocol. Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J 2005, 26:516-524.
    • (2005) Eur Heart J , vol.26 , pp. 516-524
    • Corrado, D.1    Pelliccia, A.2    Bjornstad, H.H.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.